et_marketsabout 4 hours ago
BEARISH(90%)
sell
From geopolitics to crude oil: Deepak Jorwal highlights key risks investors must track in 2026
Read original source+33.1
Market Impact Score
-100 Bearish+100 Bullish
AI Analysis
The pharma sector, while generally defensive, can be impacted by global economic slowdowns stemming from geopolitical tensions and higher crude oil prices affecting logistics and input costs. Regulatory signals and product pipelines remain crucial drivers.
Trading Insight
Maintain a selective approach in pharma, favoring companies with strong product pipelines and stable regulatory environments, while being mindful of broader market volatility.
Quick check: SUNPHARMA bearish bias (-1.3% 1d), CIPLA bearish bias (oversold).
Key Evidence
- •Deepak Jorwal of Motilal Oswal Private Wealth identifies geopolitical tensions and commodity price volatility as key risks for 2026.
- •He advises investors to maintain disciplined, diversified portfolios with global allocation.
- •Rebalancing strategies are recommended to navigate evolving risks effectively.
- •Risk flag: Increased crude oil prices impacting manufacturing and logistics costs for pharma companies.
- •Risk flag: Global economic slowdowns reducing demand for certain pharmaceutical products.
People in this Story
D
AI-powered analysis by
Anadi Algo News